mebendazole has been researched along with Abnormalities, Drug-Induced in 10 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
Excerpt | Relevance | Reference |
---|---|---|
"The Israeli Teratogen Information Service prospectively collected and followed 192 pregnancies exposed to mebendazole in pregnancy, 71." | 7.72 | Pregnancy outcome after gestational exposure to mebendazole: a prospective controlled cohort study. ( Arnon, J; Diav-Citrin, O; Lubart, I; Ornoy, A; Shechtman, S, 2003) |
"In areas endemic for hookworm, routine antenatal mebendazole therapy could greatly reduce the prevalence of anaemia in pregnancy." | 7.70 | Effect of mebendazole therapy during pregnancy on birth outcome. ( de Silva, HJ; de Silva, NR; Gunasekera, DP; Ismail, MM; Sirisena, JL, 1999) |
"The objectives of the study was to check the embryotoxic-teratogenic and fetotoxic effect of mebendazole (Vermox; Richter, Budapest, Hungary) treatment during pregnancy." | 3.73 | Population-based case-control study of mebendazole in pregnant women for birth outcomes. ( Acs, N; Bánhidy, F; Czeizel, AE; Puhó, E, 2005) |
" An enhancing role of pregnancy, which may be suspected in this case, the favourable outcome after surgery and chemotherapy, and also a mental disability in a child following long-term intrauterine exposure to mebendazole, make the report particularly unique." | 3.73 | Brain metastasis of alveolar echinococcosis in a hyperendemic focus of Echinococcus multilocularis infection. ( Craig, PS; Jones, MK; McManus, DP; Vuitton, DA; Yang, YR, 2005) |
"The Israeli Teratogen Information Service prospectively collected and followed 192 pregnancies exposed to mebendazole in pregnancy, 71." | 3.72 | Pregnancy outcome after gestational exposure to mebendazole: a prospective controlled cohort study. ( Arnon, J; Diav-Citrin, O; Lubart, I; Ornoy, A; Shechtman, S, 2003) |
"In areas endemic for hookworm, routine antenatal mebendazole therapy could greatly reduce the prevalence of anaemia in pregnancy." | 3.70 | Effect of mebendazole therapy during pregnancy on birth outcome. ( de Silva, HJ; de Silva, NR; Gunasekera, DP; Ismail, MM; Sirisena, JL, 1999) |
"Flubendazole, the p-fluoroderivative of mebendazole, was suspended in deionized water, and administered by gavage once daily to pregnant rats on days 8 through 15 of pregnancy at 0 (control), 2." | 3.67 | Teratogenicity of flubendazole in rats. ( Yoshimura, H, 1987) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (30.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 2 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Torp-Pedersen, A | 1 |
Jimenez-Solem, E | 1 |
Cejvanovic, V | 1 |
Poulsen, HE | 1 |
Andersen, JT | 1 |
Longo, M | 1 |
Zanoncelli, S | 1 |
Colombo, PA | 1 |
Harhay, MO | 1 |
Scandale, I | 1 |
Mackenzie, C | 1 |
Geary, T | 1 |
Madrill, N | 1 |
Mazué, G | 1 |
Savioli, L | 1 |
Crompton, DW | 1 |
Neira, M | 1 |
Diav-Citrin, O | 1 |
Shechtman, S | 1 |
Arnon, J | 1 |
Lubart, I | 1 |
Ornoy, A | 1 |
Acs, N | 1 |
Bánhidy, F | 1 |
Puhó, E | 1 |
Czeizel, AE | 1 |
Yang, YR | 1 |
Vuitton, DA | 1 |
Jones, MK | 1 |
Craig, PS | 1 |
McManus, DP | 1 |
de Silva, NR | 1 |
Sirisena, JL | 1 |
Gunasekera, DP | 1 |
Ismail, MM | 1 |
de Silva, HJ | 1 |
Delatour, P | 1 |
Lorgue, G | 1 |
Lapras, M | 1 |
Richard, Y | 1 |
Baskerville, M | 1 |
Wood, M | 1 |
Newton, CM | 1 |
Yoshimura, H | 1 |
10 other studies available for mebendazole and Abnormalities, Drug-Induced
Article | Year |
---|---|
Birth outcomes after exposure to mebendazole and pyrvinium during pregnancy - A Danish nationwide cohort study.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Anthelmintics; Cohort Studies; Denmark; Female; Helm | 2016 |
Effects of the benzimidazole anthelmintic drug flubendazole on rat embryos in vitro.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Animals; Anthelmintics; Biotransformation; Cel | 2013 |
Use of anthelminthic drugs during pregnancy.
Topics: Abnormalities, Drug-Induced; Anthelmintics; Female; Humans; Maternal-Fetal Exchange; Mebendazole; Pr | 2003 |
Pregnancy outcome after gestational exposure to mebendazole: a prospective controlled cohort study.
Topics: Abnormalities, Drug-Induced; Abortion, Induced; Adult; Antinematodal Agents; Birth Weight; Cohort St | 2003 |
Population-based case-control study of mebendazole in pregnant women for birth outcomes.
Topics: Abnormalities, Drug-Induced; Birth Weight; Case-Control Studies; Female; Gestational Age; Humans; In | 2005 |
Brain metastasis of alveolar echinococcosis in a hyperendemic focus of Echinococcus multilocularis infection.
Topics: Abnormalities, Drug-Induced; Anthelmintics; Brain Diseases; Central Nervous System Protozoal Infecti | 2005 |
Effect of mebendazole therapy during pregnancy on birth outcome.
Topics: Abnormalities, Drug-Induced; Antinematodal Agents; Cross-Sectional Studies; Endemic Diseases; Female | 1999 |
[Embryotoxic and antimitotic properties of parbendazole, mebendazole and cambendazole].
Topics: Abnormalities, Drug-Induced; Animals; Benzimidazoles; Cambendazole; Carcinoma, Ehrlich Tumor; Embryo | 1976 |
Mebendazole for worming mice: effectiveness and side effects.
Topics: Abnormalities, Drug-Induced; Animals; Female; Hymenolepiasis; Male; Mebendazole; Mice; Nematode Infe | 1988 |
Teratogenicity of flubendazole in rats.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Animals; Female; Fetal Resorption; Litter Size | 1987 |